DHL Group has acquired 100% of specialist pharma courier CRYOPDP from Cryoport and signed a supply chain service partnership ...

DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in ...

CRYOPDP is a leading specialty courier providing services for clinical trials, biopharma, and cell & gene therapies.

DHL Group ("DHL"), the world's leading logistics provider, and Cryoport, Inc.  ("Cryoport"), a global provider of supply chain solutions for the life sciences sector, are pleased to announce that DHL ...

This acquisition is expected to complement DHL’s existing Life Sciences and Healthcare business, which generated over EUR 5 billion in revenue in 2024. For Cryoport, which reported annual ...

The acquisition fits with DHL’s strategy to become a major player in health care logistics by 2030, with an extensive temperature-controlled network, first- and last-mile specialty courier ...

German logistics group DHL expects earnings before interest and taxes (EBIT) in its Post & Parcel division only to return to ...

CRYOPDP’s expertise in white-glove courier services, coupled with its operations in 15 countries and handling over 600,000 shipments annually, will be integrated into DHL’s Pharma Specialized Network.

Focus on logistical efficiency and compliant trade to drive mutual market expansion DHL to support Temu's local-to-local initiative, which expects to eventually account for 80% of its sales in Europe ...